Novanta outlays $1.45bn for Riverpoint Medical buyout
Novanta has agreed to acquire Riverpoint Medical for an upfront price of $1.2bn to expand its portfolio into the minimally…
09 Jun 2026
FDA clears Xenix Medical’s Lux fusion system
Xenix Medical has obtained US Food and Drug Administration (FDA) clearance for its Lux expandable lumber interbody fusion system and announced the product’s launch on the US market. Lux is…
09 Jun 2026
Stevanato unveils Deora pen injector for diabetes and weight management
Stevanato Group has introduced Deora, a multi-use, fixed-dose pen injector designed to support subcutaneous delivery of therapies for diabetes and weight management, as well as other drug development programmes. The…
09 Jun 2026
Medtronic secures CE mark for Stealth AXiS system for ENT surgery
Medtronic has received the CE mark for its Stealth AXiS surgical system, clearing the way for its use in ear, nose, and throat (ENT) procedures across Europe. The certification gives…
08 Jun 2026
FDA issues early alert for GE HealthCare’s infant resuscitation systems
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ device issue with certain GE HealthCare infant resuscitation systems and warmers. The FDA's notice points…
08 Jun 2026
ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels
New data from Dexcom has demonstrated the benefit of its G7 continuous glucose monitor (CGM) in type 2 diabetes (TD2) patients not receiving insulin, suggesting a new standard of care…
08 Jun 2026
Tandem secures CE mark for AID systems in T2D and T1D with pregnancy
Tandem Diabetes Care has received a CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The regulatory clearance covers the t:slim X2 and Tandem Mobi…